Bayer backs St. Louis hub for bioscience, innovation with $1.5M grant

Bayer has awarded a $1.5 million grant to BioSTL, a nonprofit organization dedicated to fostering growth in St. Louis' bioscience, innovation and technology community.

The grant will help fund BioSTL's new headquarters in the city's Cortex Innovation Community, and will also go toward the expansion of the organization's business development programs. To commemorate the partnership, the new facility's conference room will be named the Bayer Board Room.

BioSTL's range of offerings includes the BioGenerator investor to grow and fund companies and entrepreneurs; BioGenerator Labs, which provides startups with lab and office space and equipment; and the GlobalSTL initiative to bring high-growth international firms to the city by partnering them with local companies.

More articles on innovation:
Viewpoint: 3 ways to drive innovation among employees, customers, community
American Lung Association allots $6M in grant funding for innovative research
Innovation platforms to be instrumental in hospital growth, Partners HealthCare's Chris Coburn explains

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Webinars

Featured Whitepapers